Latest period
$11.5B
YoY change
-12.8%
5Y CAGR
+11.0%
Peak year (FY2022)
$25.9B
Latest annual
$12.3B
Total Assets history chart for Moderna (MRNA) from 2016 to 2025
Latest: $12.3B
Total Assets growth chart for Moderna (MRNA) from 2016 to 2025
Latest: -12.8%
Total Assets history table for Moderna (MRNA) from 2016 to 2025
| FY2025 | $12.3B | -12.8% | -$1.8B | ||
| FY2024 | $14.1B | -23.2% | -$4.28B | ||
| FY2023 | $18.4B | -28.7% | -$7.43B | ||
| FY2022 | $25.9B | +4.8% | +$1.19B | ||
| FY2021 | $24.7B | +236.2% | +$17.3B | ||
| FY2020 | $7.34B | +361.6% | +$5.75B | ||
| FY2019 | $1.59B | -19.0% | -$373M | ||
| FY2018 | $1.96B | +80.9% | +$878M | ||
| FY2017 | $1.08B | -23.5% | -$333M | ||
| FY2016 | $1.42B | — | — |
- FY2025$12.3B-12.8%
- FY2024$14.1B-23.2%
- FY2023$18.4B-28.7%
- FY2022$25.9B+4.8%
- FY2021$24.7B+236.2%
- FY2020$7.34B+361.6%
- FY2019$1.59B-19.0%
- FY2018$1.96B+80.9%
- FY2017$1.08B-23.5%
- FY2016$1.42B—
Total Assets values are taken from Moderna's reported balance sheets (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Total Assets at Moderna (MRNA)
According to Moderna's latest reported financial statements, the company's latest reported total assets is $11.5B. Total assets sum everything the company reports owning at the end of each reporting period — cash, receivables, inventory, property, plant, equipment, intangibles, and other holdings — as filed on the balance sheet. Compare with total liabilities and total equity for the capital-structure picture.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
The 2025 reading of Moderna (MRNA) total assets is $12.3B – declined 12.8% year-over-year.
Looking at the 2020–2025 (5 years) stretch, Moderna total assets compounded at +11.0% per year, with mixed annual results across the window.
Between 2022 and 2025, Moderna total assets plunged 52.3%, falling from $25.9B to $12.3B.
The highest annual total assets of $25.9B was reported in 2022. The lowest in the available history was $1.08B in 2017.
Moderna Total Assets by Year
Moderna Total Assets 2025: $12.3B
2025's total assets for Moderna came in at $12.3B, declined 12.8% below 2024.
Moderna Total Assets 2024: $14.1B
Moderna posted total assets of $14.1B in 2024, declined 23.2% below 2023.
Moderna Total Assets 2023: $18.4B
In 2023, Moderna reported total assets of $18.4B, declined 28.7% below 2022.
Moderna Total Assets 2022: $25.9B
Moderna total assets in 2022 was $25.9B, edged up 4.8% from 2021. This figure represents the highest annual value in the available history.
Moderna Total Assets 2021: $24.7B
Moderna total assets in 2021 was $24.7B.
See more financial history for Moderna (MRNA).
Sector peers by Total Assets
Healthcare peers of Moderna (MRNA), ranked by their latest total assets
| $310B | |
| $199B | |
| $137B | |
| $134B | |
| $112B | |
| $110B | |
| $90.6B | |
| $85.4B |
- $137B
- $134B
- $112B
- $90.6B
- $85.4B
Frequently asked questions
Test yourself on MRNA
Market Cap — 10 rounds, every one of them MRNA against another company. Leave whenever you like.
Practice run — it doesn’t move your skill rating and doesn’t touch the leaderboards. Misses do go into your review queue.
Moderna (MRNA) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
How this company returns cash to shareholders — buybacks, dividends, and stock splits.